MHRA approves 'world first' low-carbon version of COPD inhaler
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved what it says is the world’s first low-carbon version of Trixeo Aerosphere (Astra Zeneca), a triple combination inhaler for adults with moderate-to-severe COPD. The newly approved version of Trixeo Aerosphere will replace the propellant HFA-134a with HFO-1234ze(E) — a fluorinated gas with “near-zero global warming […]
Publication Details
- Journal
- Pharmaceutical journal/The pharmaceutical journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1211/pj.2025.1.356862
- Primary Topic
- Maritime Transport Emissions and Efficiency
- Type
- article
- Field-Weighted Citation Impact
- 0.00